Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 5
2018 2
2019 2
2020 2
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Tubular Secretory Solute Clearance and HIV Infection.
Garimella PS, Scherzer R, Kestenbaum BR, Hoofnagle AN, Jotwani V, Gustafson D, Karim R, Sharma A, Cohen M, Dumond J, Abraham A, Estrella M, Shlipak MG, Ix JH. Garimella PS, et al. J Acquir Immune Defic Syndr. 2023 Aug 1;93(4):319-326. doi: 10.1097/QAI.0000000000003200. J Acquir Immune Defic Syndr. 2023. PMID: 36988544 Free PMC article.
Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants.
Jotwani V, Garimella PS, Katz R, Malhotra R, Bates J, Cheung AK, Chonchol M, Drawz PE, Freedman BI, Haley WE, Killeen AA, Punzi H, Sarnak MJ, Segal MS, Shlipak MG, Ix JH; SPRINT Research Group. Jotwani V, et al. Am J Nephrol. 2020;51(10):797-805. doi: 10.1159/000509978. Epub 2020 Sep 9. Am J Nephrol. 2020. PMID: 32906135 Free PMC article. Clinical Trial.
Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.
Jotwani V, Scherzer R, Glidden DV, Mehrotra M, Defechereux P, Liu A, Gandhi M, Bennett M, Coca SG, Parikh CR, Grant RM, Shlipak MG. Jotwani V, et al. J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):169-174. doi: 10.1097/QAI.0000000000001654. J Acquir Immune Defic Syndr. 2018. PMID: 29767638 Free PMC article. Clinical Trial.
Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial.
Park M, Katz R, Shlipak MG, Weiner D, Tracy R, Jotwani V, Hughes-Austin J, Gabbai F, Hsu CY, Pfeffer M, Bansal N, Bostom A, Gutierrez O, Sarnak M, Levey A, Ix JH. Park M, et al. Am J Transplant. 2017 Oct;17(10):2640-2649. doi: 10.1111/ajt.14284. Epub 2017 Apr 26. Am J Transplant. 2017. PMID: 28371433 Free PMC article. Clinical Trial.
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
Jotwani VK, Lee AK, Estrella MM, Katz R, Garimella PS, Malhotra R, Rifkin DE, Ambrosius W, Freedman BI, Cheung AK, Raphael KL, Drawz P, Neyra JA, Oparil S, Punzi H, Shlipak MG, Ix JH; for the SPRINT Research Group. Jotwani VK, et al. Am J Nephrol. 2019;49(5):346-355. doi: 10.1159/000499531. Epub 2019 Apr 2. Am J Nephrol. 2019. PMID: 30939472 Free PMC article. Clinical Trial.
14 results